✦ LIBER ✦

K-ras oncogene mutation in cancer and precancerous lesions of the gallbladder

✍ Scribed by Sun-Whe Kim; Kyu-Hee Her; Jin-Young Jang; Woo-Ho Kim; Yong-Tae Kim; Yong-Hyun Park

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 195 KB
Volume: 75
Category: Article
ISSN: 0022-4790
DOI: 10.1002/1096-9098(200012)75:4<246::aid-jso4>3.0.co;2-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ethnic difference in the pattern of K-ra

Ethnic difference in the pattern of K-ras oncogene mutations in human colorectal cancers

✍ Naoko Hayashi; Sachiko Sugai; Isao Ito; Shoji Nakamori; Michio Ogawa; Yusuke Nak 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB 👁 2 views

Detection of K

Proliferative potential and K-ras mutati

Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union

✍ Satoshi Tanno; Takeshi Obara; Tsuneshi Fujii; Yusuke Mizukami; Ryushi Shudo; Nor 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 1 views

Recent studies have shown that anomalous pancreaticobiliary ductal union (APBD) is an important risk factor for the development of gallbladder carcinoma. Epithelial hyperplasia of the gallbladder is one of the characteristic changes, but it is not clear whether epithelial hyperplasia is a premaligna

K-ras mutation in sputum of patients wit

K-ras mutation in sputum of patients with or without lung cancer

✍ Ze'ev Ronai; Marina S. Yabubovskaya; Edith Zhang; Gennady A. Belitsky 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 1 views

K-ras mutation appears in about 60% of patients with non-small-cell lung cancer (NSCLC). This freqLency and its presence in normal appearing tissues point to the potential of ras oncogene mutation to serve as a good biomarker. Using enriched PCR (EPCR), which enables the detection of one mutant alle

ras mutation and expression of the ras-r

ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer

✍ Alan G. Casson; Sylvia M. Wilson; J. Andrea McCart; Frances P. O'Malley; Hilmi O 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 2 views

As part of our ongoing studies to characterize molecular alterations in a well-defined series of surgically resected esophageal cancers, we examined the expression of 2 rasregulated genes, whose products (osteopontin and cathepsin L) previously were shown to be associated with tumor invasion and met

The presence of K-12 ras mutations in du

The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors

✍ Nidal Younes; Noreen Fulton; Reiko Tanaka; Jeffrey Wayne; Francis H. Straus II; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

BACKGROUND. Adenocarcinomas and carcinoid tumors are

Utilization of K-ras mutations identifie

Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer

✍ Zèev Lev; Dmitry Kislitsin; Gad Rennert; Aaron Lerner 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Colorectal cancer is one of the most common malignancies in the western world. About 60,000 Americans die of colorectal cancer each year. The annual incidence rate in Israel is 40 per 100,000 persons, namely a total of 2,000 new cases each year. An important step in the progression of colorectal can